First-generation EGFR
 tyrosine kinase inhibitor therapy in 106 patients with compound EGFR
-mutated lung cancer: a single institution's clinical practice experience

First Generation ◽

Kinase Inhibitor ◽

Practice Experience ◽

Egfr Mutated

EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan

Oncology Letters ◽

10.3892/ol.2019.10942 ◽

2019 ◽

Author(s):

Ching‑Hu Chung

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Tyrosine Kinase ◽

Clinical Outcomes ◽

Kinase Inhibitor ◽

Cancer Treatments ◽

Egfr Tyrosine Kinase ◽

Re-biopsy for advanced non-small cell lung cancer after EGFR tyrosine kinase inhibitor therapy: CT characteristics of patients with T790M mutation and the use of various re-biopsy procedures

Annals of Oncology ◽

10.1093/annonc/mdx091.023 ◽

2017 ◽

Vol 28 ◽

pp. ii37-ii38

Author(s):

H.J. Koo ◽

M.Y. Kim ◽

C.-M. Choi ◽

J.C. Lee ◽

S. Park

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

T790m Mutation ◽

Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer

Clinical Cancer Research ◽

10.1158/1078-0432.12aacriaslc-b34 ◽

2012 ◽

Vol 18 (3 Supplement) ◽

pp. B34-B34

Author(s):

Rafael Sierra ◽

Anderson Chang ◽

Jason Moffat ◽

Benjamin G. Neel ◽

Ming-Sound Tsao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Abstract 1232: Overcoming resistance to EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

10.1158/1538-7445.am2012-1232 ◽

2012 ◽

Author(s):

J Rafael Sierra ◽

Anderson Chang ◽

Jason Moffat ◽

Benjamin G. Neel ◽

Ming-Sound Tsao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz063.030 ◽

2019 ◽

Vol 30 ◽

pp. ii51

Author(s):

J. Fassunke ◽

C. Heydt ◽

S. Michels ◽

B. Van Veggel ◽

F. Müller ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Resistance Mechanisms ◽

Third Generation ◽

Egfr Tyrosine Kinase ◽

New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy

Lung Cancer ◽

10.1016/j.lungcan.2010.10.019 ◽

2011 ◽

Vol 73 (1) ◽

pp. 63-69 ◽

Cited By ~ 31

Author(s):

Ho Yun Lee ◽

Kyung Soo Lee ◽

Myung-Ju Ahn ◽

Hye Sun Hwang ◽

Ju Won Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2009.12.009 ◽

2010 ◽

Vol 69 (1) ◽

pp. 1-12 ◽

Cited By ~ 36

Author(s):

Robert C. Doebele ◽

Ana B. Oton ◽

Nir Peled ◽

D. Ross Camidge ◽

Paul A. Bunn

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

New Strategies

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study

Targeted Oncology ◽

10.1007/s11523-015-0387-4 ◽

2015 ◽

Vol 11 (2) ◽

pp. 167-174 ◽

Cited By ~ 10

Author(s):

J. B. Auliac ◽

C. Fournier ◽

C. Audigier Valette ◽

M. Perol ◽

A. Bizieux ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutated

The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer

Value in Health ◽

10.1111/j.1524-4733.2008.00415.x ◽

2009 ◽

Vol 12 (1) ◽

pp. 20-27 ◽

Cited By ~ 63

Author(s):

Josh J. Carlson ◽

Louis P. Garrison ◽

Scott D. Ramsey ◽

David L. Veenstra

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Integrative omics analysis reveals soluble cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-3972 ◽

2020 ◽

pp. clincanres.3972.2019

Author(s):

Ting-Feng Hsiao ◽

Chih-Liang Wang ◽

Yi-Cheng Wu ◽

Hsiang-Pu Feng ◽

Yen-Chuan Chiu ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Egfr Tyrosine Kinase ◽

Survival Predictor ◽

Integrative Omics